Compare FULC & FFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FULC | FFIC |
|---|---|---|
| Founded | 2015 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 687.4M | 557.3M |
| IPO Year | 2019 | 1995 |
| Metric | FULC | FFIC |
|---|---|---|
| Price | $10.76 | $15.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | $16.38 | ★ $16.80 |
| AVG Volume (30 Days) | ★ 788.8K | 422.1K |
| Earning Date | 02-24-2026 | 01-27-2026 |
| Dividend Yield | N/A | ★ 5.58% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $226,144,000.00 |
| Revenue This Year | N/A | $16.86 |
| Revenue Next Year | N/A | $6.01 |
| P/E Ratio | ★ N/A | $29.19 |
| Revenue Growth | ★ 2752.05 | 96.65 |
| 52 Week Low | $2.32 | $10.65 |
| 52 Week High | $15.74 | $17.79 |
| Indicator | FULC | FFIC |
|---|---|---|
| Relative Strength Index (RSI) | 50.01 | 51.02 |
| Support Level | $10.39 | $15.13 |
| Resistance Level | $11.28 | $16.74 |
| Average True Range (ATR) | 0.76 | 0.48 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 76.29 | 46.65 |
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.